Literature DB >> 2661425

Endothelium and control of vascular function. State of the Art lecture.

P M Vanhoutte1.   

Abstract

The response of isolated blood vessels to a variety of vasoactive agonists is modulated by the presence of endothelial cells. Indeed, these cells can release both dilator and constrictor substances. The major endothelium-derived relaxing factor may be nitric oxide, which activates soluble guanylate cyclase in the smooth muscle, although the endothelial cells also secrete an unidentified hyperpolarizing factor. Among the natural stimuli for the release of endothelium-derived relaxing factors are circulating hormones, platelet products, thrombin, shear stress, and certain autacoids. Endothelium-derived relaxing factors may contribute to the regulation of the release of atrial natriuretic factor and renin. The endothelial cells can also release constricting factors; among the likely candidates are superoxide anions or the peptide endothelin. In hypertensive blood vessels, the ability to release endothelium-derived relaxing factors but not endothelium-derived contracting factors is blunted.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2661425     DOI: 10.1161/01.hyp.13.6.658

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  89 in total

Review 1.  Age-related endothelial dysfunction : potential implications for pharmacotherapy.

Authors:  Rachel L Matz; Ramaroson Andriantsitohaina
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

2.  Effect of endothelium removal on the vasoconstrictor response to neuronally released 5-hydroxytryptamine and noradrenaline in the rat isolated mesenteric and femoral arteries.

Authors:  M Urabe; H Kawasaki; K Takasaki
Journal:  Br J Pharmacol       Date:  1991-01       Impact factor: 8.739

Review 3.  Endothelial dysfunction in diabetes: multiple targets for treatment.

Authors:  Hong Ding; Chris R Triggle
Journal:  Pflugers Arch       Date:  2010-03-18       Impact factor: 3.657

Review 4.  CD4+CD25+Foxp3 regulatory T cells and vascular dysfunction in hypertension.

Authors:  Modar Kassan; Andrea Wecker; Philip Kadowitz; Mohamed Trebak; Khalid Matrougui
Journal:  J Hypertens       Date:  2013-10       Impact factor: 4.844

Review 5.  Canonical transient receptor potential channels in diabetes.

Authors:  Sarabeth Graham; Joseph P Yuan; Rong Ma
Journal:  Exp Biol Med (Maywood)       Date:  2012-01-26

Review 6.  Quinapril: a further update of its pharmacology and therapeutic use in cardiovascular disorders.

Authors:  Christine R Culy; Blair Jarvis
Journal:  Drugs       Date:  2002       Impact factor: 9.546

7.  Uncoupling protein-2 mediates DPP-4 inhibitor-induced restoration of endothelial function in hypertension through reducing oxidative stress.

Authors:  Limei Liu; Jian Liu; Xiao Yu Tian; Wing Tak Wong; Chi Wai Lau; Aimin Xu; Gang Xu; Chi Fai Ng; Xiaoqiang Yao; Yuansheng Gao; Yu Huang
Journal:  Antioxid Redox Signal       Date:  2014-03-12       Impact factor: 8.401

8.  Bradykinin antagonist counteracts the acute effect of both angiotensin-converting enzyme inhibition and of angiotensin receptor blockade on the lower limit of autoregulation of cerebral blood flow.

Authors:  Sigurdur T Sigurdsson; Olaf B Paulson; Arne Høj Nielsen; Svend Strandgaard
Journal:  J Cereb Blood Flow Metab       Date:  2013-12-11       Impact factor: 6.200

9.  Salt-dependent inhibition of epithelial Na+ channel-mediated sodium reabsorption in the aldosterone-sensitive distal nephron by bradykinin.

Authors:  Mykola Mamenko; Oleg Zaika; Peter A Doris; Oleh Pochynyuk
Journal:  Hypertension       Date:  2012-10-01       Impact factor: 10.190

10.  Test-retest reliability of pulse wave velocity in individuals with chronic spinal cord injury.

Authors:  Masae Miyatani; Kei Masani; Cameron Moore; Maggie Szeto; Maggie Szato; Paul Oh; Catharine Craven
Journal:  J Spinal Cord Med       Date:  2012-09       Impact factor: 1.985

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.